Texas Retina Associates

Texas Retina Associates Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Texas Retina Associates, Ophthalmologist, 1040 Texan Trail, Suite 100, Grapevine, TX.

“Dr. Rene Choi is an exceptional ophthalmologist, distinguished by his unwavering integrity and outstanding kindness and...
10/27/2025

“Dr. Rene Choi is an exceptional ophthalmologist, distinguished by his unwavering integrity and outstanding kindness and compassion towards his patients. He combines superb clinical and surgical skills in treating retinal and inflammatory diseases with a genuinely warm demeanor. It has been some years since completing training, and he continues to be solidly regarded as one of the most effective and beloved fellows to have graduated from OHSU Casey Eye Institute.”

— Andy Lauer, MD, Chair and Director of Ophthalmology at the Casey Eye Institute, Past Chair and Director, American Board of Ophthalmology

At AAO 2025, the American Academy of annual meeting held in Orlando, Florida, October 18-20, 2025, our own Dr. Rene Y. Choi was presented the “One to Watch” award, a peer-nominated honor given to upcoming doctors in the field of retina who are considered future leaders.

Learn more in our latest blog: https://www.texasretina.com/2025/10/26/texas-retinas-dr-rene-choi-receives-one-to-watch-award-at-aao-2025

We’re excited to announce that on October 14, 2025, Texas Retina broke ground on a brand new, state-of-the-art eye care ...
10/23/2025

We’re excited to announce that on October 14, 2025, Texas Retina broke ground on a brand new, state-of-the-art eye care complex to better serve the Frisco, Texas community. Scheduled to open in late 2026, this new office will eventually replace our current Frisco office.

At twice the size, it will better serve our patients in this rapidly growing area while also incorporating space for clinical research and a dedicated ophthalmology ambulatory surgical center (ASC) available for retina surgeries as well as for general ophthalmology and a full range of ophthalmology subspecialty surgical procedures.

Learn more: https://www.texasretina.com/2025/10/23/texas-retina-breaks-ground-on-new-frisco-ophthalmology-complex

Prevent Blindness has declared October 20–26, 2025, as Inflammatory Eye Disease Awareness Week. While there are several ...
10/21/2025

Prevent Blindness has declared October 20–26, 2025, as Inflammatory Eye Disease Awareness Week. While there are several inflammatory eye conditions, the one we specialize in at Texas Retina is called uveitis.

Early diagnosis and appropriate treatment are critical to preserving vision and preventing complications of this rare, complex condition. There are only around 40 combined retina/uveitis specialists in the entire U.S., and at Texas Retina, we are fortunate to have two physicians who are fellowship-trained in both. Dr. Robert C. Wang and Dr. Rene Y. Choi sub-specialize in diagnosing and caring for patients with uveitis and are also on the forefront of investigating better treatments through clinical research.

Learn more about how we diagnose and treat uveitis in our latest blog: https://www.texasretina.com/2025/10/20/how-do-we-diagnose-and-treat-uveitis

At Texas Retina, we want our patients to feel comfortable about their care plan and work hard to earn their confidence a...
10/17/2025

At Texas Retina, we want our patients to feel comfortable about their care plan and work hard to earn their confidence and trust. A big part of that is taking the time to listen to any concerns and clearly communicating all treatment options and care provided. That is why we’re grateful for this positive feedback about Dr. Williams and his team.

He cares for patients in our Arlington, Fort Worth and Grapevine offices, and serves as our Director of Clinical Research for Fort Worth. You can learn more about Dr. Williams here: https://www.texasretina.com/our-physicians/patrick-d-williams-md

“This new trial will determine if neoadjuvant therapy with an oral agent called darovasertib, which is given before plaq...
10/13/2025

“This new trial will determine if neoadjuvant therapy with an oral agent called darovasertib, which is given before plaque radiation, will lead to less vision loss from plaque therapy. In addition, for patients with tumors too large for radiation, this therapy could possibly provide an option to maintain their eye rather than have it enucleated. Our hope is that darovasertib can shrink the tumor enough to allow for plaque treatment.” – Timothy Fuller, MD

Under the leadership of principal investigator Dr. Timothy Fuller, Texas Retina will soon begin enrolling patients in the OptimUM-10 clinical trial, a randomized, Phase III, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma (neoadjuvant means therapy before definitive treatment like plaque placement or eye removal).

Learn more: https://www.texasretina.com/2025/10/13/texas-retina-participating-in-new-phase-iii-clinical-trial-for-uveal-melanoma

Did you know that wearing protective eyewear could prevent 90% of eye injuries? October is Eye Injury Prevention Month, ...
10/08/2025

Did you know that wearing protective eyewear could prevent 90% of eye injuries?

October is Eye Injury Prevention Month, and the temperatures in Texas are finally starting to cool down a bit. Whether you are tackling a home improvement project or enjoying some fall fun in the sun, Texas Retina reminds you to protect your eyes from both injury and sun damage. We share four steps you can take in our latest blog: https://www.texasretina.com/2025/10/08/eye-injury-prevention-month-four-tips-to-protect-your-eyes

“The most fulfilling part of my work is developing lasting connections with patients while helping them preserve or rega...
09/30/2025

“The most fulfilling part of my work is developing lasting connections with patients while helping them preserve or regain their sight. Whether through navigating a complex diagnosis or performing delicate surgery, I find purpose in knowing that my efforts can make a lasting difference in someone’s quality of life.” – Benjamin R. Lin, MD

Board-certified ophthalmologist and retina specialist Dr. Benjamin R. Lin joined Texas Retina in September after completing his training at the world-renowned Bascom Palmer Eye Institute at the University of Miami in Florida. He cares for patients in our Dallas Main, Dallas North and Plano offices. Get to know Dr. Lin better in our latest blog: https://www.texasretina.com/2025/09/30/getting-to-know-benjamin-r-lin-md

We’re ending the week on a high note with this fantastic review about Dr. Castillo and our Waco team!
09/26/2025

We’re ending the week on a high note with this fantastic review about Dr. Castillo and our Waco team!

For many retinal diseases like age-related macular degeneration, diabetic retinopathy and uveitis, an eye injection (als...
09/23/2025

For many retinal diseases like age-related macular degeneration, diabetic retinopathy and uveitis, an eye injection (also called an intravitreal injection) is the only way we can deliver potentially sight-saving medication where it is needed in the back of your eye.

In our latest blog, we share answers to some of the most frequently asked questions about eye injections that we hear from patients at Texas Retina: https://www.texasretina.com/2025/09/23/frequently-asked-questions-about-eye-injections

At Texas Retina, we know anything affecting your sight can be scary. That is why we take the time to truly listen to our...
09/19/2025

At Texas Retina, we know anything affecting your sight can be scary. That is why we take the time to truly listen to our patients’ concerns and clearly communicate all treatment options and care provided. It’s about treating our patients as we would our own families.

Today we’re grateful for this recent feedback about Dr. Timothy Fuller. He cares for patients in our Dallas Main and Athens offices. In addition to providing medical retina care, he also sub-specializes in treating ocular cancer.

Learn more about Dr. Timothy Fuller here: https://www.texasretina.com/our-physicians/timothy-s-fuller-md

On behalf of the VERONA study investigators, Texas Retina’s Dr. Ashkan Abbey delivered a presentation at the 58th Annual...
09/16/2025

On behalf of the VERONA study investigators, Texas Retina’s Dr. Ashkan Abbey delivered a presentation at the 58th Annual Scientific Meeting of The Retina Society held September 10-13, 2025, in Chicago, Illinois.

The Phase 2 VERONA clinical trial evaluated the durability, safety and efficacy of EYP-1901 in patients with active, previously treated diabetic macular (DME) compared to a control arm that received aflibercept. The aim of EYP-1901, a sustained release tyrosine kinase inhibitor (TKI), is to reduce the frequency of treatments needed compared to current standard-of-care anti-VEGF intravitreal injections.

Learn more in our latest blog: https://www.texasretina.com/2025/09/16/dr-abbey-spoke-about-the-verona-diabetic-macular-edema-clinical-trial-at-the-retina-societys-annual-meeting

Address

1040 Texan Trail, Suite 100
Grapevine, TX
76051

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Texas Retina Associates posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category